Abstract
Neurological disease and disorders remain a large public health threat. Thus, research to improve early detection and/or develop more effective treatment approaches are necessary. Although there are many common techniques and imaging modalities utilized to study these diseases, existing approaches often require a label which can be costly and time consuming. Matrix-assisted laser desorption ionization (MALDI) imaging mass spectrometry (IMS) is a label-free, innovative and emerging technique that produces 2D ion density maps representing the distribution of an analyte(s) across a tissue section in relation to tissue histopathology. One main advantage of MALDI IMS over other imaging modalities is its ability to determine the spatial distribution of hundreds of analytes within a single imaging run, without the need for a label or any a priori knowledge. Within the field of neurology and disease there have been several impactful studies in which MALDI IMS has been utilized to better understand the cellular pathology of the disease and or severity. Furthermore, MALDI IMS has made it possible to map specific classes of analytes to regions of the brain that otherwise may have been lost using more traditional methods. This review will highlight key studies that demonstrate the potential of this technology to elucidate previously unknown phenomenon in neurological disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andrews WT, Donahue D, Holmes A, Balsara R, Castellino FJ, Hummon AB (2020) In situ metabolite and lipid analysis of GluN2D-/- and wild-type mice after ischemic stroke using MALDI MSI. Anal Bioanal Chem 412(24):6275–6285. https://doi.org/10.1007/s00216-020-02477-z
Angel PM, Bayoumi AS, Hinton RB, Ru SuY, Bichell D, Mayer JE, Scott Baldwin H, Caprioli RM (2016) MALDI imaging mass spectrometry as a lipidomic approach to heart valve research. J Heart Valve Dis 25(2):240–252
Angel PM, Mehta A, Norris-Caneda K, Drake RR (2018) MALDI imaging mass spectrometry of N-glycans and tryptic peptides from the same formalin-fixed paraffin-embedded tissue section. Methods Mol Biol 1788:225–241. https://doi.org/10.1007/7651_2017_81
Arribat Y, Talmat-Amar Y, Paucard A, Lesport P, Bonneaud N, Bauer C, Bec N, Parmentier M, Benigno L, Larroque C, Maurel P, Maschat F (2014) Systemic delivery of P42 peptide: a new weapon to fight Huntington’s disease. Acta Neuropathol Commun 2:86. https://doi.org/10.1186/s40478-014-0086-x
Balluff B, McDonnell LA (2018) Mass spectrometry imaging of metabolites. Methods Mol Biol 1730:345–357. https://doi.org/10.1007/978-1-4939-7592-1_26
Barry JA, Groseclose MR, Castellino S (2019) Quantification and assessment of detection capability in imaging mass spectrometry using a revised mimetic tissue model. Bioanalysis 11(11):1099–1116. https://doi.org/10.4155/bio-2019-0035
Besser M, Wank R (1999) Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors. J Immunol 162(11):6303–6306
Bivehed E, Stromvall R, Bergquist J, Bakalkin G, Andersson M (2016) Region-specific bioconversion of dynorphin neuropeptide detected by in situ histochemistry and MALDI imaging mass spectrometry. Peptides 87:20–27
Bogie JF, Jorissen W, Mailleux J, Nijland PG, Zelcer N, Vanmierlo T, Van Horssen J, Stinissen P, Hellings N, Hendriks JJ (2013) Myelin alters the inflammatory phenotype of macrophages by activating PPARs. Acta Neuropathol Commun 1:43. https://doi.org/10.1186/2051-5960-1-43
Bowman AP, Bogie JFJ, Hendriks JJA, Haidar M, Belov M, Heeren RMA, Ellis SR (2020) Evaluation of lipid coverage and high spatial resolution MALDI-imaging capabilities of oversampling combined with laser post-ionization. Anal Bioanal Chem 412(10):2277–2289. https://doi.org/10.1007/s00216-019-02290-3
Calvano CD, Monopoli A, Cataldi TRI, Palmisano F (2018) MALDI matrices for low molecular weight compounds: an endless story? Anal Bioanal Chem 410:4015–4038. https://doi.org/10.1007/s00216-018-1014-x
Caprioli RM, Farmer TB, Gile J (1997) Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal Chem 1997(69):4751–4760
Carlred L, Gunnarsson A, Solé-Domènech S, Johansson B, Vukojević V, Terenius L, Codita A, Winblad B, Schalling M, Höök F, Sjövall P (2014) Simultaneous imaging of amyloid-β and lipids in brain tissue using antibody-coupled liposomes and time-of-flight secondary ion mass spectrometry. J Am Chem Soc 136(28):9973–9981. https://doi.org/10.1021/ja5019145
Carlred L, Vukojević V, Johansson B, Schalling M, Höök F, Sjövall P (2016) Imaging of amyloid-β in Alzheimer’s disease transgenic mouse brains with ToF-SIMS using immunoliposomes. Biointerphases 11(2):02A312. https://doi.org/10.1116/1.4940215
Caughlin S, Hepburn J, Park D, Jurcic K, Yeung K, Cechetto D, Whitehead S (2015) Increased expression of simple ganglioside species GM2 and GM3 detected by MALDI imaging mass spectrometry in a combined rat model of Aβ toxicity and stroke. Plos One. 10(6): e0130364. https://doi.org/10.1371/journal.pone.0130364
Caughlin S, Hepburn J, Liu Q, Wang L, Yeung KK, Cechetto DF, Whitehead SN (2019) Chloroquine restores ganglioside homeostasis and improves pathological and behavioral outcomes post-stroke in the rat. Mol Neurobiol 56(5):3552–3562. https://doi.org/10.1007/s12035-018-1317-0
Centers for Disease Control and Prevention (CDC2003) (2003) National Center for Injury Prevention and Control. Report to Congress on mild traumatic brain injury in the United States: steps to prevent a serious public health problem. Centers for Disease Control and Prevention, Atlanta
Centers for Disease Control and Prevention (2019) Surveillance Report of Traumatic Brain Injury-related Emergency Department Visits, Hospitalizations, and Deaths—United States, 2014. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Chatterji B, Dickhut C, Mielke S, Krüger J, Just I, Glage S, Meier M, Wedekind D, Pich A (2014) MALDI imaging mass spectrometry to investigate endogenous peptides in an animal model of Usher’s disease. Proteomics 14(13–14):1674–1687. https://doi.org/10.1002/pmic.201300558
Chen K, Baluya D, Tosun M, Li F, Maletic-Savatic M (2019) Imaging mass spectrometry: a new tool to assess molecular underpinnings of neurodegeneration. Metabolites 9(7):135. https://doi.org/10.3390/metabo9070135
Chen Y, Allegood J, Liu Y, Wang E, Cachón-Gonzalez B, Cox T, Merrill A, Sullards M (2008) Imaging MALDI mass spectrometry using an oscillating capillary nebulizer matrix coating system and its application to analysis of lipids in brain from a mouse model of Tay-Sachs/sandhoff disease. 80(8):2780–2788. https://doi.org/10.1021/ac702350g
Chew H, Solomon VA, Fonteh AN (2020) Involvement of lipids in Alzheimer’s disease pathology and potential therapies. Front Physiol 11:598. https://doi.org/10.3389/fphys.2020.00598
Chughtai K, Heeren R (2010) Mass Spectrometric Imaging for biomedical tissue analysis. Chem Rev 110(5):3237–3277. https://doi.org/10.1021/cr100012c
Dufresne M, Guneysu D, Patterson N, Marcinkiewicz M, Regina A, Demeule M, Chaurand P (2017) Multimodal detection of GM2 and GM3 lipid species in the brain of mucopolysaccharidosis type II mouse by serial imaging mass spectrometry and immunohistochemistry. Anal Bioanal Chem 409(5):1425–1433. https://doi.org/10.1007/s00216-016-0076-x
Esteve C, Tolner EA, Shyti R, van den Maagdenberg AMJM, McDonnell LA (2016) Mass spectrometry imaging of amino neurotransmitters: a comparison of derivatization methods and application in mouse brain tissue. Metabolomics 12:30. https://doi.org/10.1007/s11306-015-0926-0
Esteve C, Jones EA, Kell DB, Boutin H, McDonnell LA (2017) Mass spectrometry imaging shows major derangements in neurogranin and in purine metabolism in the triple-knockout 3xTg Alzheimer mouse model. Biochim Biophys Acta 1865:747–754
Feigin VL, Vos T, Nichols E, Owolabi MO, Carroll WM, Dichgans M, Deuschl G, Parmar P, Brainin M, Murray C (2019) The global burden of neurological disorders: translating evidence into policy. Lancet Neurol 3:255–265. https://doi.org/10.1016/S1474-4422(19)30411-9
Freitas-Andrade M, Bechberger J, Wang J, Yeung KKC, Whitehead SN, Hansen RS, Naus CC (2020) Danegaptide enhances astrocyte gap junctional coupling and reduces ischemic reperfusion brain injury in mice. Biomolecules 10(3):353. https://doi.org/10.3390/biom10030353.PMID:32110860;PMCID:PMC7175267
Grajchen E, Hendriks JJA, Bogie JFJ (2018) The physiology of foamy phagocytes in multiple sclerosis. Acta Neuropathol Commun 6(1):124. https://doi.org/10.1186/s40478-018-0628-8
Hanrieder J (2011) Alterations of striatal neuropeptides revealed by imaging mass spectrometry. Mol Cell Proteomics
Hanrieder J, Ljungdahl A, Andersson M (2012a) MALDI imaging mass spectrometry of neuropeptides in Parkinson’s disease. J vis Exp 60:3445. https://doi.org/10.3791/3445
Hanrieder J, Ljungdahl A, Andersson M (2012b) MALDI imaging mass spectrometry of neuropeptides in Parkinson’s disease. J vis Exp 60:3345
Henderson F, Hart PJ, Pradillo JM, Kassiou M, Christie L, Williams KJ, Boutin H, McMahon A (2018) Multi-modal imaging of long-term recovery post-stroke by positron emission tomography and matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom 32(9):721–729. https://doi.org/10.1002/rcm.8090 (PMID: 29484723)
Hohlfeld R, Kerschensteiner M, Stadelmann C, Lassmann H, Wekerle H (2006) The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. Neurol Sci 27(Suppl 1):S1-7. https://doi.org/10.1007/s10072-006-0537-7
Hunter M, Demarais N, Faull R, Grey A, Curtis M (2018) Subventricular zone lipidomic architecture loss in Huntington’s disease. J Neurochem 146(5):613–630. https://doi.org/10.1111/jnc.14468
Jarmusch A, Pirro V, Baird Z, Hattab E, Cohen-Gadol A, Cooks R (2016) Lipid and metabolite profiles of human brain tumors by desorption electrospray ionization-MS. PNAS 113(6):1486–1491. https://doi.org/10.1073/pnas.1523306113
Jones E, Dworski S, Canals D, Casas J, Fabrias G, Schoenling D, Levade T, Denlinger C, Hannum Y, Medin J, Drake R (2014) On-tissue localization of ceramides and other sphingolipids by MALDI mass spectrometry imaging. Anal Chem 86(16):8303–8311. https://doi.org/10.1021/ac501937d
Jones E, Quiason C, Dale S, Shahidi-Latham SK (2017a) Feasibility assessment of a MALDI FTICR imaging approach for the 3D reconstruction of a mouse lung. J Am Soc Mass Spectrom 28(8):1709–1715. https://doi.org/10.1007/s13361-017-1658-3
Jones E, Zhang W, Zhao X, Quiason C, Dale S, Shahidi-Latham S, Grabowski G, Setchell K, Drake R, Sun Y (2017b) Tissue localization of glycosphingolipid accumulation in a Gaucher disease mouse brain by LC-ESI-MS/MS and high-resolution MALDI imaging mass spectrometry. SLAS Discov 22(10):1218–1228. https://doi.org/10.1177/2472555217719372
Kakuda N, Miyasaka T, Iwasaki N, Nirasawa T, Wada-Kakuda S, Takahashi-Fujigasaki J, Murayama S, Ihara Y, Ikegawa M (2017) Distinct deposition of amyloid-β species in brains with Alzheimer’s disease pathology visualized with MALDI imaging mass spectrometry. Acta Neuropathol Commun 5:73
Karlsson O, Hanrieder J (2017) Imaging mass spectrometry in drug development and toxicology. Arch Toxicol 91:2283–2294. https://doi.org/10.1007/s00204-016-1905-6
Kaya I, Brinet D, Michno W, Baskurt M, Zetterberg H, Blenow K, Hanrieder J (2017a) Novel trimodal MALDI imaging mass spectrometry (IMS3) at 10 µm reveals spatial lipid and peptide correlates implicated in Aβ plaque pathology in Alzheimer’s disease. ACS Chem Neurosci 8:2778–2790
Kaya I, Michno W, Brinet D, Iacone Y, Zanni G, Blennow K, Zetterberg H, Hanrieder J (2017b) Histology-compatible MALDI mass spectrometry based imaging of neuronal lipids for subsequent immunofluorescent staining. Anal Chem 89(8):4685–4694. https://doi.org/10.1021/acs.analchem.7b00313
Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WE, Kolbeck R, Hoope E, Oropeza-Wekerle RL, Bartke I, Stadelmann C, Lassmann H, Wekerle H, Hohlfeld R (1999) Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med 189(5):865–870. https://doi.org/10.1084/jem.189.5.865
Lagarrigue M, Alexandrov T, Dieuset G, Perrin A, Lavigne R, Baulac S, Thiele H, Martin B, Pineau C (2012) New analysis workflow for MALDI imaging mass spectrometry: application to the discovery and identification of potential markers of childhood absence epilepsy. J Proteome Res 11(11):5453–5463. https://doi.org/10.1021/pr3006974 (PMID: 22994238)
Lazar A, Bich C, Panchal M, Desbenoit N, Petit V, Touboul D, Dauphinot L, Marquer C, Laprévote O, Brunelle A, Duyckaerts C (2012) Time-of-flight secondary ion mass spectrometry (TOF-SIMS) imaging reveals cholesterol overload in the cerebral cortex of Alzheimer disease patients. Acta Neuropathol 125(1):133–144. https://doi.org/10.1007/s00401-012-1041-1
León M, Ferreira C, Eberlin L, Pirro V, Rodrigues A, Favaron P, Miglino M, Cooks R (2019) Metabolites and lipids associated with fetal swine anatomy via desorption electrospray ionization – Mass spectrometry imaging. Sci Rep 9(1):7247. https://doi.org/10.1038/s41598-019-43698-2
Leopold J, Popkova Y, Engel K, Schiller J (2018) Recent developments of useful MALDI matrices for the mass spectrometric characterization of lipids. Biomolecules 8:173. https://doi.org/10.3390/biom8040173
Maccarrone G, Nischwitz S, Deininger SO, Hornung J, König FB, Stadelmann C, Turck CW, Weber F (2017) MALDI imaging mass spectrometry analysis-A new approach for protein mapping in multiple sclerosis brain lesions. J Chromatogr B Analy Technol Biomed Life Sci 1047:131–140. https://doi.org/10.1016/j.jchromb.2016.07.001
Mailleux J, Vanmierlo T, Bogie JF, Wouters E, Lütjohann D, Hendriks JJ, van Horssen J (2018) Active liver X receptor signaling in phagocytes in multiple sclerosis lesions. Mult Scler 24(3):279–289. https://doi.org/10.1177/1352458517696595
Mallah K, Quanico J, Raffo-Romero A, Cardon T, Aboulouard S, Devos D, Kobeissy F, Zibara K, Salzet M, Fournier I (2019) Matrix-assisted laser desorption/ionization-mass spectrometry imaging of lipids in experimental model of traumatic brain injury detecting acylcarnitines as injury related markers. Anal Chem 91(18):11879–11887. https://doi.org/10.1021/acs.analchem.9b02633
McDonald WS, Jones EE, Wojciak JM, Drake RR, Sabbadini RA, Harris NG (2018) Matrix-assisted laser desorption ionization mapping of lysophosphatidic acid changes after traumatic brain injury and the relationship to cellular pathology. Am J Pathol 188(8):1779–1793. https://doi.org/10.1016/j.ajpath.2018.05.005
Mendis LH, Grey AC, Faull RLM, Curtis MA (2016) Hippocampal lipid differences in Alzheimer’s disease: a human brain study using matrix-assisted laser desorption/ioni. Brain Behav 6(10):e00517
Mulder IA, Ogrinc Potočnik N, Broos LAM, Prop A, Wermer MJH, Heeren RMA, van den Maagdenberg AMJM (2019) Distinguishing core from penumbra by lipid profiles using mass spectrometry imaging in a transgenic mouse model of ischemic stroke. Sci Rep 9(1):1090. https://doi.org/10.1038/s41598-018-37612-5
Najem D, Rennie K, Ribecco-Lutkiewicz M, Ly D, Haukenfrers J, Liu Q, Nzau M, Fraser DD, Bani-Yaghoub M (2018) Traumatic brain injury: classification, models, and markers. Biochem Cell Biol 96(4):391–406. https://doi.org/10.1139/bcb-2016-0160
Neumann EK, Djambazova KV, Caprioli RM, Spraggins JM (2020) Multimodal imaging mass spectrometry: next generation molecular mapping in biology and medicine. J Am Soc Mass Spectrom. https://doi.org/10.1021/jasms.0c00232
O’Rourke MB, Smith CC, De La Monte SM, Sutherland GT, Padula MP (2019) Higher mass accuracy MALDI-TOF/TOF lipid imaging of human brain tissue in Alzheimer’s disease. Curr Protoc Mol Biol 126(1):e86. https://doi.org/10.1002/cpmb.86
Pavlovic D, Pekic S, Stojanovic M, Popovic V (2019) Traumatic brain injury: neuropathological, neurocognitive and neurobehavioral sequelae. Pituitary 3:270–282. https://doi.org/10.1007/s11102-019-00957-9
Perry EK, McKeith I, Thompson P, Marshall E, Kerwin J, Jabeen S, Edwardson JA, Ince P, Blessed G, Irving D, Perry RH (1991) Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson’s disease, and Alzheimer’s disease. Ann NY Acad Sci 640:197–202
Perry WJ, Weiss A, Van de Plas R, Spraggins JM, Caprioli RM, Skaar EP (2020) Integrated molecular imaging technologies for investigation of metals in biological systems: a brief review. Curr Opin Chem Biol 55:127–135. https://doi.org/10.1016/j.cbpa.2020.01.008
Ryan DJ, Spraggins JM, Caprioli RM (2019) Protein identification strategies in MALDI imaging mass spectrometry: a brief review. Curr Opin Chem Biol 48:64–72. https://doi.org/10.1016/j.cbpa.2018.10.023
Rzagalinski I, Hainz N, Meier C, Tschernig T, Volmer DA (2019) Spatial and molecular changes of mouse brain metabolism in response to immunomodulatory treatment with teriflunomide as visualized by MALDI-MSI. Anal Bioanal Chem 411(2):353–365. https://doi.org/10.1007/s00216-018-1444-5
Schwamborn K, Caprioli RM (2010) MALDI imaging mass spectrometry–painting molecular pictures. Mol Oncol 4(6):529–538. https://doi.org/10.1016/j.molonc.2010.09.002
Sekera ER, Saraswat D, Zemaitis KJ, Sim FJ, Wood TD (2020) MALDI mass spectrometry imaging in a primary demyelination model of murine spinal cord. J Am Soc Mass Spectrom. https://doi.org/10.1021/jasms.0c00187
Severiano D, Oliveira-Lima O, Vasconcelos G, Marques B, Carvalho G, Freitas E, Xavier C, Gomez M, Pinheiro A, Gomez R, Boniek V, Pinto M (2020) Cerebral lipid dynamics in chronic cerebral hypoperfusion model by DESI-MS imaging. Neuroscience 426:1–12. https://doi.org/10.1016/j.neuroscience.2019.11.014
Shanta SR, Kim TY, Hong JH, Lee JH, Shin CY, Kim KH, Kim YH, Kim SK, Kim KP (2012) A new combination MALDI matrix for small molecule analysis: application to imaging mass spectrometry for drugs and metabolites. Analyst 137(24):5757–5762. https://doi.org/10.1039/c2an35782h
Shariatgorji M, Nilsson A, Goodwin RJA, Kälback P, Schintu N, Zhang X, Crossman AR, Bezard E, Svenningsson P, Andren PE (2014a) Direct targeted quantitative molecular imaging of neurotransmitters in brain tissue sections. Neuron 84:697–707. https://doi.org/10.1016/j.neuron.2014.10.011
Shariatgorji M, Svenningsson P, Andrén PE (2014b) Mass spectrometry imaging, an emerging technology in neuropsychopharmacology. Neuropsychopharmacology 39(1):34–49. https://doi.org/10.1038/npp.2013.215
Shariatgorji M, Nilsson A, Fridjonsdottir E, Vallianatou T, Källback P, Katan L, Sävmarker J, Mantas I, Zhang X, Bezard E, Svenningsson P, Odell LR, Andrén PE (2019) Comprehensive mapping of neurotransmitter networks by MALDI-MS imaging. Nat Methods 16(10):1021–1028. https://doi.org/10.1038/s41592-019-0551-3
Sparvero LJ, Amoscato AA, Fink AB, Anthonymuthu T, New LA, Kochanek PM, Watkins S, Kagan VE, Bayır H (2016) Imaging mass spectrometry reveals loss of polyunsaturated cardiolipins in the cortical contusion, hippocampus, and thalamus after traumatic brain injury. J Neurochem 139(4):659–675. https://doi.org/10.1111/jnc.13840
Stübiger G, Belgacem O (2007) Analysis of lipids using 2,4,6-trihydroxyacetophenone as a matrix for MALDI mass spectrometry. Anal Chem 79(8):3206–3213. https://doi.org/10.1021/ac062236c
Sugiura Y, Honda K, Kajimura M, Suematsu M (2014) Visualization and quantification of cerebral metabolic fluxes of glucose in awake mice. Proteomics 14(7–8):829–838. https://doi.org/10.1002/pmic.201300047
Sugiyama E, Guerrini M, Honda K, Hattori Y, Abe M, Kallback P, Andren PE, Tanaka KF, Setou M, Fagarasan S, Suematsu M, Sugiura Y (2019) Detection of a high-turnover serotonin circuit in the mouse brain using mass spectrometry imaging. iScience 20:359–372
Tanaka E, Ogawa Y, Fujii R, Shimonaka T, Sato Y, Hamazaki T, Nagamura-Inoue T, Shintaku H, Tsuji M (2020) Metabolomic analysis and mass spectrometry imaging after neonatal stroke and cell therapies in mouse brains. Sci Rep 10(1):21881. https://doi.org/10.1038/s41598-020-78930-x
Tikka S, Monogioudi E, Gotsopoulos A, Soliymani R, Pezzini F, Scifo E, Uusi-Rauva K, Tyynelä J, Baumann M, Jalanko A, Simonati A, Lalowski M (2016) Proteomic profiling in the brain of CLN1 disease model reveals affected functional modules. Neuromol Med 18(1):109–133. https://doi.org/10.1007/s12017-015-8382-6
Tobias F, Olson M, Cologna S (2018) Mass spectrometry imaging of lipids: untargeted consensus spectra reveal spatial distributions on Niemann-Pick disease type C1. J Lipid Res 59(12):2446–2455. https://doi.org/10.1194/jlr.D086090
Torcia M, Bracci-Laudiero L, Lucibello M, Nencioni L, Labardi D, Rubartelli A, Cozzolino F, Aloe L, Garaci E et al (1996) Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 85(3):345–356. https://doi.org/10.1016/s0092-8674(00)81113-7
Ullman JC, Arguello A, Getz JA, Bhalla A, Mahon CS, Wang J, Giese T, Bedard C, Kim DJ, Blumenfeld JR, Liang N, Ravi R, Nugent AA, Davis SS, Ha C, Duque J, Tran HL, Wells RC, Lianoglou S, Daryani VM, Kwan W, Solanoy H, Nguyen H, Earr T, Dugas JC, Tuck MD, Harvey JL, Reyzer ML, Caprioli RM, Hall S, Poda S, Sanchez PE, Dennis MS, Gunasekaran K, Srivastava A, Sandmann T, Henne KR, Thorne RG, Di Paolo G, Astarita G, Diaz D, Silverman AP, Watts RJ, Sweeney ZK, Kariolis MS, Henry AG (2020) Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in mice. Sci Transl Med 12(545):eaay1163. https://doi.org/10.1126/scitranslmed.aay1163
Verbeeck N, Spraggins JM, Murphy MJM, Wang H, Deutch AY, Caprioli RM, Van de Plas R (2017) Connecting imaging mass spectrometry and magnetic resonance imaging-based anatomical atlases for automated anatomical interpretation and differential analysis. Biochimca 1865(7):967–977
Vickerman JC (2011) Molecular imaging and depth profiling by mass spectrometry—SIMS MALDI or DESI?. The Analyst 136(11) 2199. https://doi.org/10.1039/c1an00008j
Wang C, Zhang J, Tang J, Li YY, Gu Y, Yu Y, Xiong J, Zhao X, Zhang Z, Li TT, Chen J, Wan Q, Zhang Z (2018a) Lysophosphatidic acid induces neuronal cell death via activation of asparagine endopeptidase in cerebral ischemia-reperfusion injury. Exp Neurol 306:1–9. https://doi.org/10.1016/j.expneurol.2018.04.010
Wang JSH, Freitas-Andrade M, Bechberger JF, Naus CC, Yeung KK, Whitehead SN (2018b) Matrix-assisted laser desorption/ionization imaging mass spectrometry of intraperitoneally injected danegaptide (ZP1609) for treatment of stroke-reperfusion injury in mice. Rapid Commun Mass Spectrom 32(12):951–958. https://doi.org/10.1002/rcm.8115
Watrous JD, Alexandrov T, Dorrestein PC (2011) The evolving field of imaging mass spectrometry and its impact on future biological research. J Mass Spectrom 46(2):209–222. https://doi.org/10.1002/jms.1876
Whitehead SN, Chan KH, Gangaraju S, Slinn J, Li J, Hou ST (2011) Imaging mass spectrometry detection of gangliosides species in the mouse brain following transient focal cerebral ischemia and long-term recovery. PLoS ONE 6(6):e20808. https://doi.org/10.1371/journal.pone.0020808
Zemski Berry KA, Hankin JA, Barkley RM, Spraggins JM, Caprioli RM, Murphy RC (2011) MALDI imaging of lipid biochemistry in tissues by mass spectrometry. Chem Rev 111(10):6491–6512. https://doi.org/10.1021/cr200280p
Funding
No funding was utilized within this manuscript as all the data was from other research groups and it is a review.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All the Data discussed herein is referenced and there is a table with the PubMed links to the original manuscripts included in the text, Table 3.
No animals were utilized here or humans for research. Thus, this article does not contain any studies with human participants performed by any of the authors.
Conflicts of interest/Competing interest
The views in this review reflect the author’s own individual interpretation of the work and not that of the FDA. There are no conflicts of interest for any of the authors listed.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Schnackenberg, L.K., Thorn, D.A., Barnette, D. et al. MALDI imaging mass spectrometry: an emerging tool in neurology. Metab Brain Dis 37, 105–121 (2022). https://doi.org/10.1007/s11011-021-00797-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-021-00797-2